KYMR

Kymera Therapeutics, Inc.

•Healthcare

Loading Chart...

FIT ANALYSIS

Required for personalization

FIT ANALYSIS

Checking Membership...

STOCK DNA

Similar Stocks

CCCC C4 Therapeutics, Inc.

GLUE Monte Rosa Therapeutics, Inc.

CRVS Corvus Pharmaceuticals, Inc.

ELOX Eloxx Pharmaceuticals, Inc.

VYNE VYNE Therapeutics Inc.

Health Indicators

Price Trend

Upwards

Momentum

Neutral

Balance Sheet

High Leverage

Earnings

Stable

Dividend Yield

0.00%

Market Cap

$9.66B

TALK TO YOUR STOCK

EQUITAI ASSISTANT

I have initialized the database workspace for Kymera Therapeutics, Inc. (KYMR). I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.

Talk to Your Stock•open live chat

Pro EquitAI Research

Retrieving premium status...